|Publication number||US4149405 A|
|Application number||US 05/867,878|
|Publication date||Apr 17, 1979|
|Filing date||Jan 9, 1978|
|Priority date||Jan 10, 1977|
|Publication number||05867878, 867878, US 4149405 A, US 4149405A, US-A-4149405, US4149405 A, US4149405A|
|Original Assignee||Battelle, Centre De Recherche De Geneve|
|Export Citation||BiBTeX, EndNote, RefMan|
|Patent Citations (3), Referenced by (49), Classifications (9), Legal Events (1)|
|External Links: USPTO, USPTO Assignment, Espacenet|
The present invention relates to the determination of the viscosity of a fluid material and, more particularly, to a method of and a device for determining the viscosity of fluid materials or the coagulation of blood or blood plasma.
In order to measure the viscosity of a fluid substance a certain deformation force can be exerted on this substance and the resistance offered by the substance can be measured. Although blood coagulation is not strictly speaking a viscosity, its measurement can be closely paralleled with that of a viscosity measurement in that a sample is subjected to a particular deformation force and the deformation is observed.
Blood coagulation is the result of a particularly complex biochemical process which is caused according to the type by different combinations of a plurality of components called "factors" contained in the blood. At the present twelve factors are said to play a role in this process.
Interactions between these factors lead in the case of normal blood to the formation of a filamentary network called fibrin, the production of which is characteristic of coagulation. The purpose of the coagulometer is to detect the exact instant of the formation of this network.
The coagulation of blood in the laboratory has been initiated heretofore by several different methods each relying on the use of a respective different group of factors as a function of the information desired. The choice of methods allows one to eliminate or to accentuate the action of different factors in the blood. The sample is either whole blood or plasma. In most cases this blood or this plasma is prevented from coagulating by the addition of an anticoagulant to the fresh blood, this anticoagulant being constituted by a solution of trisodium citrate or sodium oxalate. The plasmas of blood treated with one or the other of these solutions is called "citrated plasma" or "oxalated plasma". These solutions have the effect of eliminating Ca++ ions from the blood, following which the plasma is separated by centrifuging.
Most coagulometers in use read out the time of incipient appearance of the fibrin. There is a wide variety of electromechanical measuring devices for coagulation in use in laboratories. Many of these devices are rather imprecise and disturb the blood during the coagulation process. Most require a relatively large quantity of blood as the sample and only measure a single point in the coagulation process, not allowing one to measure the evolution of this process. As a rule these devices cannot be used for all coagulation measurements.
Although in many cases the numerical measurement of the process is sufficient, for example for monitoring the administration of anticoagulant substances, it is occasionally useful to know more about the entire evolution of the process, for instance to advance research in this field and to allow more precise diagnoses.
There are so-called "thromboelastographs" which record coagulation graphs. As a result of their complexity such devices cannot be used for running analyses.
The very newest devices meant for use in analytic laboratories are photometric devices which measure the absorption by the sample of a light beam. The formation of fibrin, which is characteristic of coagulation, increasingly diffuses the light of the beam. The remaining light, and as a result the absorbance of the sample, is measured by a photoelectric cell placed across from the source of light, this cell and this source being to opposite sides of the sample.
This analysis system has two advantages over those which have existed to date. No object touches the sample during analysis, and the signal picked up is analog and usable for drawing a graph indicating the evolution of the process.
Nonetheless the basic principle on which this apparatus operates is incompatible with certain analytical methods or for certain pathogenic forms of plasma or blood. The analysis of whole blood is effectively ruled out by the fact that such blood is too opaque. This detection method is in addition poorly adapted for measuring the coagulation of exalted plasmas because they are disturbed during the process. For certain diseases, lipemia for example, the plasma is cloudy, thereby falsifying the measurement. Finally the evaluation of the formation of fibrin is very temporary with such a device.
There are fields other than hematology wherein the measurement of viscosity itself sometimes poses problems that are only inadequately solved, in particular measurement of the viscosity of non-Newtonian liquids. As is known this viscosity is mainly a function of the speed of deformation of these liquids. As a result their measurement can only be made by applying different deformation speeds at a constant temperature so that the viscosity is a curve illustrating a function of these speeds of deformation. In any case the known viscosimeters hardly allow one to measure viscosities at deformation speeds less than 1 sec-1. On the other hand the determination of the viscosity at a very small deformation speed is of interest because it allows one to determine a molecular weight of a polymer.
An object of the present invention is to overcome at least in part the above-given disadvantages.
The above and other objects are attained, in accordance with the invention, in a process for measuring the viscosity of a fluid substance, in particular the evolution of blood coagulation, as a function of time, in that a sample to be measured is placed on a support, a beam of light is directed against the free surface of this sample, the sample is vibrated at a given frequency and amplitude so as to disturb its free surface and the light reflected by a portion of this surface, which is characteristic of the viscosity of this sample, is measured.
The above and other objects, features and advantages of the present invention will become more readily apparent from the following description, reference being made to the accompanying drawing in which:
FIG. 1 is a side-elevational view of an apparatus for carrying out the method of the present invention;
FIG. 2 is a diagram illustrating the functioning of the apparatus and the treatment of the signal obtained;
FIGS. 3-5 are three graphs of tests of coagulation of three different samples; and
FIG. 6 is a graph showing the viscosity of a polymer as a function of the deformation speed which is applied to it.
The apparatus of FIG. 1 comprises a support 1 carrying an electromagnet 2 and an arm 3 pivoted about an axle 4 and whose degree of motion is determined by an abutment 5 spaced from the electromagnet 2. A return spring 6 biases the arm 3 against the abutment 5. This arm 3 carries a plate 7 adapted to carry the sample. Preferably this plate is formed of a synthetic-resin material such as Delrin rather than glass whose influence on the coagulation process is known.
A light source 8 is aimed at the center of the plate and a photoelectric receiver 9 is placed at a location determined by the reflected light. As will be seen below when the arm 3 is at rest, the receiver 9 can either receive the light reflected from the surface of the sample carried by the plate 7 or receive no light.
The principle on which the method is based consists of forming on the plate 7 a drop of the sample calibrated in such a manner that its shape can be reproduced. This sample is either formed of whole blood or of plasmas and an appropriate reagent. When the sample is placed on the plate, this plate is vibrated and the surface of the drop is irradicated. The vibrations which deform the surface of this drop disturb the light reflected by this surface. As soon as coagulation starts the influence of the vibrations on the surface of this drop diminish progressively so that the amount of reflected light received by the receiver 9 varies until the coagulation is complete. If the receiver 9 is normally positioned in the path of the beam of reflected light the quantity of light received will vary from a minimum to a maximum between the start and the end of the process period. However if the receiver 9 is normally outside of this path, the vibrations communicated to the drop of the sample before coagulation make the deformed surface of this drop reflect a part of the light toward the cell 9 and this quantity will decrease as the coagulation reduces the extent of the deformations transmitted to the surface of the drop.
In the arrangement shown in FIG. 1 the vibrations are caused by the electromagnet 2 fed by current pulses at a frequency from 2-4 Hz. These pulses vibrate the arm 3 urged by the spring 6 between the electromagnet 2 and the abutment 5.
Different tests have been carried out with the aid of equipment similar to that illustrated in FIG. 1 by treating the detected signals from the receiver 9 as shown in FIG. 2. In this diagram four series of signals a, b, c and d are shown. The signals a represent the feed pulses for the magnet 2, the signals b correspond to the excitation current of the photoelectric receiver 9 caused by the light received from a reflection of the light incident against the surface of the drop of the sample being vibrated as the electromagnet is excited. This current is proportional to the light received by the receiver and is as a result a function of the deformation of the surface of the drop of the sample being vibrated. The signal c corresponds to the integral of the signal b. The signal d corresponds to the value of the peaks of the signal c and is used for forming the curves of FIGS. 3-5.
The tests carried out to evaluate the performance of this method consist in measuring the time of prothrombin of a citrated control sample sold commercially and whose normal prothrombin time is known.
In order to measure the coagulation with this method the plasma is heated to 37° C. 30 μl are pipetted onto the plate 7 also heated to 37° C. Then on this same plate 60 μl of a reagent are deposited, normally a solution of thromboplastine and calcium chloride which has been heated to 37° C. The addition of this reagent determines very exactly the time t0 corresponding to the start of measurement and to the start of the excitation of the electromagnet 2 by the train of pulses a (FIG. 2) which vibrates the plate 7. The signal treated as described above is fed to a recording instrument which traces a curve similar to that of FIG. 3. On this curve the prothrombin time is given by t1 which corresponds to the beginning of the formation of fibrin. Most of prior-art devices only allow determination of this time t1. The process according to the invention allows in addition the following of the evolution of the coagulation process until its end.
The diagram of FIGS. 4 and 5 show the use of this graphic analytical method for the coagulation process. The traph of FIG. 4 was traced by using the same control plasma as mentioned above, but diluted to 50% of artificial serum, whereas the graph of FIG. 4 corresponds to this same control plasma diluted to 75% of artificial serum. It can be seen that in these two cases not only does the time t1 vary as a function of the dilution of the plasma, but that the shape of the curve between t1 and t2 is very different. This shows that the process of the invention allows the detection in addition to the prothrombine time of the complete coagulation time which itself varies noticeably as a function of the density of the fibrin network which forms not only at its start but also during the process. It is of course possible to observe the process of coagulation by introducing other "factors" than the method described. In all these cases the same mechanical phenomena would produce the same effects independent of the intervening factors in the coagulation process.
In addition to certain advantages of the process already mentioned it is also important to point out that the plasma is subjected to minimal disturbances during the coagulation process. The detecting devices of the process do not contact the substance which is reacting. The measuring process according to the invention is usable for all known methods no matter what the nature of the sample to be analyzed. In the tests tried the quantity of the sample is particularly small. At the same time nothing prevents it from being reduced further, the critical problem then being only that of the precision of the pipetting. The results obtained can be given either in numerical form or in analog form or even in both of these forms. The apparatus necessary for carrying out the process is extremely simple.
In addition to measuring the evolution of sanguine coagulation, the process described above is also in interest for the measurement of the viscosity of non-Newtonian liquids. It is not considered possible to measure the viscosity for deformation speeds smaller than 1 sec-1 with known viscosimeters. Knowing the viscosity at small deformation speeds would, however, be important because it would allow one to determine the molecular weight of a polymer.
The process, according to the invention, produces an output which is a function of the forces dissipated in the liquid and, therefore, of its viscosity. The vibration to which the sample is subjected allows one to communicate to it a very small deformation speed. As seen in FIG. 6 which shows the viscosity curves of three polyethylenes it is possible to note that as the deformation speed D goes to zero the measured viscosity η corresponds practically to ηo. This means that it is possible with the process, according to the invention, to measure the viscosity ηo of a polymer.
|Cited Patent||Filing date||Publication date||Applicant||Title|
|US3077764 *||Oct 30, 1959||Feb 19, 1963||Standard Oil Co||Pour point instrument|
|US3650698 *||Dec 4, 1969||Mar 21, 1972||Technicon Corp||Apparatus for the automatic determination of the coagulation, aggregation and or flocculation, or the like, rates of fluids, and novel reaction intensifying agent for use therewith|
|US3752443 *||Dec 13, 1971||Aug 14, 1973||Technicon Instr||Magnetic mixer|
|Citing Patent||Filing date||Publication date||Applicant||Title|
|US5686661 *||Jun 4, 1996||Nov 11, 1997||Mississippi State University||In-situ, real time viscosity measurement of molten materials with laser induced ultrasonics|
|US6019735 *||Aug 28, 1997||Feb 1, 2000||Visco Technologies, Inc.||Viscosity measuring apparatus and method of use|
|US6077234 *||Jun 23, 1998||Jun 20, 2000||Visco Technologies, Inc.||In-vivo apparatus and method of use for determining the effects of materials, conditions, activities, and lifestyles on blood parameters|
|US6152888 *||Sep 21, 1999||Nov 28, 2000||Visco Technologies, Inc.||Viscosity measuring apparatus and method of use|
|US6193667||Nov 15, 1999||Feb 27, 2001||Visco Technologies, Inc.||Methods of determining the effect(s) of materials, conditions, activities and lifestyles|
|US6200277||Nov 15, 1999||Mar 13, 2001||Visco Technologies, Inc.||In-vivo apparatus and methods of use for determining the effects of materials, conditions, activities, and lifestyles on blood parameters|
|US6261244||Aug 25, 1999||Jul 17, 2001||Visco Technologies, Inc.||Viscosity measuring apparatus and method of use|
|US6322524||Nov 12, 1999||Nov 27, 2001||Visco Technologies, Inc.||Dual riser/single capillary viscometer|
|US6322525||Feb 10, 2000||Nov 27, 2001||Visco Technologies, Inc.||Method of analyzing data from a circulating blood viscometer for determining absolute and effective blood viscosity|
|US6402703||May 18, 2000||Jun 11, 2002||Visco Technologies, Inc.||Dual riser/single capillary viscometer|
|US6412336||Jul 2, 2001||Jul 2, 2002||Rheologics, Inc.||Single riser/single capillary blood viscometer using mass detection or column height detection|
|US6428488||Jul 12, 2000||Aug 6, 2002||Kenneth Kensey||Dual riser/dual capillary viscometer for newtonian and non-newtonian fluids|
|US6450974||Nov 8, 2000||Sep 17, 2002||Rheologics, Inc.||Method of isolating surface tension and yield stress in viscosity measurements|
|US6484565||Jul 2, 2001||Nov 26, 2002||Drexel University||Single riser/single capillary viscometer using mass detection or column height detection|
|US6484566||Nov 27, 2000||Nov 26, 2002||Rheologics, Inc.||Electrorheological and magnetorheological fluid scanning rheometer|
|US6564618||Jul 17, 2002||May 20, 2003||Rheologics, Inc.||Electrorheological and magnetorheological fluid scanning rheometer|
|US6571608||May 28, 2002||Jun 3, 2003||Rheologics, Inc.||Single riser/single capillary viscometer using mass detection or column height detection|
|US6598465||Jul 1, 2002||Jul 29, 2003||Rheologics, Inc.||Electrorheological and magnetorheological fluid scanning rheometer|
|US6624435||Dec 27, 2001||Sep 23, 2003||Rheologics, Inc.||Dual riser/dual capillary viscometer for newtonian and non-newtonian fluids|
|US6732573||Apr 22, 2002||May 11, 2004||Rheologics, Inc.||Single riser/single capillary blood viscometer using mass detection or column height detection|
|US6745615||Oct 9, 2001||Jun 8, 2004||Rheologics, Inc.||Dual riser/single capillary viscometer|
|US6796168||Sep 17, 2002||Sep 28, 2004||Rheologics, Inc.||Method for determining a characteristic viscosity-shear rate relationship for a fluid|
|US6805674||Jun 28, 2002||Oct 19, 2004||Rheologics, Inc.||Viscosity measuring apparatus and method of use|
|US6845327 *||Jun 8, 2001||Jan 18, 2005||Epocal Inc.||Point-of-care in-vitro blood analysis system|
|US6907772||Apr 23, 2004||Jun 21, 2005||Rheologics, Inc.||Dual riser/single capillary viscometer|
|US7261861 *||Apr 24, 2003||Aug 28, 2007||Haemoscope Corporation||Hemostasis analyzer and method|
|US7857761 *||Apr 16, 2004||Dec 28, 2010||Drexel University||Acoustic blood analyzer for assessing blood properties|
|US7879615||Jun 22, 2006||Feb 1, 2011||Coramed Technologies, Llc||Hemostasis analyzer and method|
|US8236568||Jun 1, 2007||Aug 7, 2012||Coramed Technologies, Llc||Method for analyzing hemostasis|
|US20020040196 *||Oct 9, 2001||Apr 4, 2002||Kenneth Kensey||Dual riser/single capillary viscometer|
|US20030148530 *||Jun 8, 2001||Aug 7, 2003||Lauks Imants R.||Point-of-care in-vitro blood analysis system|
|US20030158500 *||Feb 13, 2003||Aug 21, 2003||Kenneth Kensey||Decreasing pressure differential viscometer|
|US20040194538 *||Apr 23, 2004||Oct 7, 2004||Rheologics, Inc.||Dual riser/single capillary viscometer|
|US20040214337 *||Apr 24, 2003||Oct 28, 2004||Hans Kautzky||Hemostasis analyzer and method|
|US20050015001 *||Apr 16, 2004||Jan 20, 2005||Lec Ryszard M.||Acoustic blood analyzer for assessing blood properties|
|US20070092405 *||Jun 22, 2006||Apr 26, 2007||Haemoscope Corporation||Hemostasis Analyzer and Method|
|US20070224686 *||Jun 1, 2007||Sep 27, 2007||Haemoscope Corporation||Method for Analyzing Hemostasis|
|US20070237677 *||Jun 1, 2007||Oct 11, 2007||Haemoscope Corporation||Resonant Frequency Hemostasis Analyzer|
|EP1039295A2 *||Mar 10, 2000||Sep 27, 2000||Holger Behnk||System for measuring the coagulation of body fluids|
|EP1039295A3 *||Mar 10, 2000||Jul 11, 2001||Holger Behnk||System for measuring the coagulation of body fluids|
|EP1039296A1 *||Mar 19, 1999||Sep 27, 2000||Holger Behnk||System for measuring coagulation of bodily fluids|
|WO1999010724A2||Aug 26, 1998||Mar 4, 1999||Visco Technologies, Inc.||Viscosity measuring apparatus and method of use|
|WO1999066839A1||Jun 22, 1999||Dec 29, 1999||Visco Technologies, Inc.||In-vivo determining the effects of a pharmaceutical on blood parameters|
|WO2001036936A1||Oct 12, 2000||May 25, 2001||Rheologics, Inc.||Dual riser/single capillary viscometer|
|WO2001058356A2||Feb 7, 2001||Aug 16, 2001||Rheologics, Inc.||Method for determining absolute and effective blood viscosity|
|WO2001086255A1 *||May 8, 2001||Nov 15, 2001||Trustees Of Tufts College||Method and apparatus for determining local viscoelasticity|
|WO2002009583A2||Jul 30, 2001||Feb 7, 2002||Rheologics, Inc.||Apparatus and methods for comprehensive blood analysis, including work of, and contractility of, heart and therapeutic applications and compositions thereof|
|WO2003020133A2||Jul 31, 2002||Mar 13, 2003||Rheologics, Inc.||Method for determining the viscosity of an adulterated blood sample over plural shear rates|
|WO2006110963A1 *||Apr 21, 2006||Oct 26, 2006||K.U.Leuven Research And Development||Monitoring of the v1sco-elastic properties of gels and liquids|
|U.S. Classification||73/54.01, 356/39|
|International Classification||G01N11/00, G01N33/86, G01N33/49|
|Cooperative Classification||G01N33/4905, G01N11/00|
|European Classification||G01N33/49B, G01N11/00|
|Dec 2, 1988||AS||Assignment|
Owner name: INTRACEL CORPORATION, C/O COTTLE CATFORD & CO., BA
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNOR:BATTELLE MEMORIAL INSTITUTE;REEL/FRAME:005001/0948
Effective date: 19880914